title: Erlotinib-induced thrombocytosis in patients with recurrence of pancreatic cancer after distal pancreatectomy.
authors.affiliation: Department of Surgery and Department of Medical Oncology and Hematology The Jikei University School of Medicine Tokyo, Japan uwatadashi@msn.com Department of Surgery The Jikei University School of Medicine Tokyo, Japan Department of Medical Oncology and Hematology The Jikei University School of Medicine Tokyo, Japan Department of Surgery The Jikei University School of Medicine Tokyo, Japan.
authors.forename: Tadashi
authors.initials: T
authors.lastname: Uwagawa
authors.forename: Takeyuki
authors.initials: T
authors.lastname: Misawa
authors.forename: Yuki
authors.initials: Y
authors.lastname: Fujiwara
authors.forename: Kenei
authors.initials: K
authors.lastname: Furukawa
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Tsutsui
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Kitamura
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Shiba
authors.forename: Yasuro
authors.initials: Y
authors.lastname: Futagawa
authors.forename: Keisuke
authors.initials: K
authors.lastname: Aiba
authors.forename: Katsuhiko
authors.initials: K
authors.lastname: Yanaga
mesh_terms: D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D000069347:Erlotinib Hydrochloride; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D010976:Platelet Count; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects*; D013156:Splenectomy / Q000009:adverse effects; D013922:Thrombocytosis / Q000097:blood / Q000139:chemically induced*; D000093542:Gemcitabine
chemical_list: D011799:Quinazolines; D003841:Deoxycytidine; D000069347:Erlotinib Hydrochloride; D000093542:Gemcitabine